Cargando…

Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome

The main symptoms of Meige's syndrome are involuntary eye blinking with muddled speech and uncontrollable contraction of the platysma muscle characterized by segmental, primarily oromandibular, dystonia (hyperkinesia). It can also develop after long‐term medication of first‐ and second‐generati...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Tomihiko, Mochida, Masahiko, Matsumi, Tatsunaru, Yoshimoto, Katsuhiko, Tatebayashi, Yoshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292264/
https://www.ncbi.nlm.nih.gov/pubmed/31743613
http://dx.doi.org/10.1002/npr2.12081
_version_ 1783546074812645376
author Uemura, Tomihiko
Mochida, Masahiko
Matsumi, Tatsunaru
Yoshimoto, Katsuhiko
Tatebayashi, Yoshitaka
author_facet Uemura, Tomihiko
Mochida, Masahiko
Matsumi, Tatsunaru
Yoshimoto, Katsuhiko
Tatebayashi, Yoshitaka
author_sort Uemura, Tomihiko
collection PubMed
description The main symptoms of Meige's syndrome are involuntary eye blinking with muddled speech and uncontrollable contraction of the platysma muscle characterized by segmental, primarily oromandibular, dystonia (hyperkinesia). It can also develop after long‐term medication of first‐ and second‐generation antipsychotics. Here, we report the case of a Japanese female schizophrenic patient comorbid with Meige's syndrome and hyperthyroidism. We discuss the relationship between the three diseases, that is, schizophrenia, Meige's syndrome, and hyperthyroidism. Our intention is to consider the important role of the cerebral basal ganglia, where little attention has been given in regard to schizophrenia and Meige's syndrome. A part of this article was presented in a poster section at the joint congress of the 28th Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology and the 48th Annual Meeting of the Japanese Society of Neuropsychopharmacology held in 2018.
format Online
Article
Text
id pubmed-7292264
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72922642020-12-08 Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome Uemura, Tomihiko Mochida, Masahiko Matsumi, Tatsunaru Yoshimoto, Katsuhiko Tatebayashi, Yoshitaka Neuropsychopharmacol Rep Case Report The main symptoms of Meige's syndrome are involuntary eye blinking with muddled speech and uncontrollable contraction of the platysma muscle characterized by segmental, primarily oromandibular, dystonia (hyperkinesia). It can also develop after long‐term medication of first‐ and second‐generation antipsychotics. Here, we report the case of a Japanese female schizophrenic patient comorbid with Meige's syndrome and hyperthyroidism. We discuss the relationship between the three diseases, that is, schizophrenia, Meige's syndrome, and hyperthyroidism. Our intention is to consider the important role of the cerebral basal ganglia, where little attention has been given in regard to schizophrenia and Meige's syndrome. A part of this article was presented in a poster section at the joint congress of the 28th Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology and the 48th Annual Meeting of the Japanese Society of Neuropsychopharmacology held in 2018. John Wiley and Sons Inc. 2019-11-19 /pmc/articles/PMC7292264/ /pubmed/31743613 http://dx.doi.org/10.1002/npr2.12081 Text en © 2019 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsycho Pharmacology. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Uemura, Tomihiko
Mochida, Masahiko
Matsumi, Tatsunaru
Yoshimoto, Katsuhiko
Tatebayashi, Yoshitaka
Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome
title Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome
title_full Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome
title_fullStr Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome
title_full_unstemmed Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome
title_short Therapy‐refractory schizophrenia in a patient who previously suffered from Meige’s syndrome
title_sort therapy‐refractory schizophrenia in a patient who previously suffered from meige’s syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292264/
https://www.ncbi.nlm.nih.gov/pubmed/31743613
http://dx.doi.org/10.1002/npr2.12081
work_keys_str_mv AT uemuratomihiko therapyrefractoryschizophreniainapatientwhopreviouslysufferedfrommeigessyndrome
AT mochidamasahiko therapyrefractoryschizophreniainapatientwhopreviouslysufferedfrommeigessyndrome
AT matsumitatsunaru therapyrefractoryschizophreniainapatientwhopreviouslysufferedfrommeigessyndrome
AT yoshimotokatsuhiko therapyrefractoryschizophreniainapatientwhopreviouslysufferedfrommeigessyndrome
AT tatebayashiyoshitaka therapyrefractoryschizophreniainapatientwhopreviouslysufferedfrommeigessyndrome